KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Profit After Tax (2016 - 2025)

Historic Profit After Tax for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $132.1 million.

  • West Pharmaceutical Services' Profit After Tax rose 153.73% to $132.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $493.7 million, marking a year-over-year increase of 20.3%. This contributed to the annual value of $493.7 million for FY2025, which is 20.3% up from last year.
  • According to the latest figures from Q4 2025, West Pharmaceutical Services' Profit After Tax is $132.1 million, which was up 153.73% from $140.0 million recorded in Q3 2025.
  • West Pharmaceutical Services' 5-year Profit After Tax high stood at $188.5 million for Q2 2022, and its period low was $89.8 million during Q1 2025.
  • For the 5-year period, West Pharmaceutical Services' Profit After Tax averaged around $141.4 million, with its median value being $138.5 million (2023).
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 11336.57% in 2021, then plummeted by 3132.12% in 2022.
  • Over the past 5 years, West Pharmaceutical Services' Profit After Tax (Quarter) stood at $147.7 million in 2021, then tumbled by 30.26% to $103.0 million in 2022, then surged by 33.01% to $137.0 million in 2023, then dropped by 5.04% to $130.1 million in 2024, then rose by 1.54% to $132.1 million in 2025.
  • Its Profit After Tax stands at $132.1 million for Q4 2025, versus $140.0 million for Q3 2025 and $131.8 million for Q2 2025.